Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Grabbe

Showing results (31-40 of 325) with videos related to

Pageof 33
Sort By:
International Journal of Molecular Sciences|July 26, 2018
Interleukin-1 Beta-A Friend or Foe in Malignancies?Rebekka Bent, Lorna Moll, Stephan Grabbe, et al.
Deutsche Medizinische Wochenschrift (1946)|March 23, 2026
[85-year-old female patient with scaly skin lesions]Guido Michels, Cornelia S L Müller, Stephan Grabbe
The Journal of Investigative Dermatology|August 31, 2012
Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitisTetsuya Honda, Gyohei Egawa, Stephan Grabbe, et al.
Cells|February 9, 2024
Integrins in Health and Disease-Suitable Targets for Treatment?Tanja Klaus, Christoph Hieber, Matthias Bros, et al.
Dermatologic Therapy|March 3, 2020
Merkel cell carcinoma-derived Erysipelas carcinomatosumMohamad Goldust, Jaqueline Heinz, Mrinal Gupta, et al.
Archives of Dermatological Research|November 9, 2006
Influence of pH on wound-healing: a new perspective for wound-therapy?Lars Alexander Schneider, Andreas Korber, Stephan Grabbe, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 18, 2022
Ulrike Nikfarjam, Joanna Wegner, Stephan Grabbe, et al.
Cancers|April 12, 2022
Immunomodulatory Properties of Immune Checkpoint Inhibitors-More than Boosting T-Cell Responses?Michael Kuske, Maximilian Haist, Thomas Jung, et al.
Melanoma Research|December 16, 2016
New-onset third-degree atrioventricular block because of autoimmune-induced myositis under treatment with anti-programmed cell death-1 (nivolumab) for metastatic melanomaJuliane Behling, Joachim Kaes, Thomas Münzel, et al.
Trends in Immunology|November 9, 2004
DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapyJoachim L Schultze, Stephan Grabbe, Michael S von Bergwelt-Baildon
Pageof 33

Showing results (31-40 of 325) with videos related to

Sort By:
Pageof 33
International Journal of Molecular Sciences|July 26, 2018
Interleukin-1 Beta-A Friend or Foe in Malignancies?Rebekka Bent, Lorna Moll, Stephan Grabbe, et al.
Deutsche Medizinische Wochenschrift (1946)|March 23, 2026
[85-year-old female patient with scaly skin lesions]Guido Michels, Cornelia S L Müller, Stephan Grabbe
The Journal of Investigative Dermatology|August 31, 2012
Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitisTetsuya Honda, Gyohei Egawa, Stephan Grabbe, et al.
Cells|February 9, 2024
Integrins in Health and Disease-Suitable Targets for Treatment?Tanja Klaus, Christoph Hieber, Matthias Bros, et al.
Dermatologic Therapy|March 3, 2020
Merkel cell carcinoma-derived Erysipelas carcinomatosumMohamad Goldust, Jaqueline Heinz, Mrinal Gupta, et al.
Archives of Dermatological Research|November 9, 2006
Influence of pH on wound-healing: a new perspective for wound-therapy?Lars Alexander Schneider, Andreas Korber, Stephan Grabbe, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 18, 2022
Ulrike Nikfarjam, Joanna Wegner, Stephan Grabbe, et al.
Cancers|April 12, 2022
Immunomodulatory Properties of Immune Checkpoint Inhibitors-More than Boosting T-Cell Responses?Michael Kuske, Maximilian Haist, Thomas Jung, et al.
Melanoma Research|December 16, 2016
New-onset third-degree atrioventricular block because of autoimmune-induced myositis under treatment with anti-programmed cell death-1 (nivolumab) for metastatic melanomaJuliane Behling, Joachim Kaes, Thomas Münzel, et al.
Trends in Immunology|November 9, 2004
DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapyJoachim L Schultze, Stephan Grabbe, Michael S von Bergwelt-Baildon
Pageof 33